Immuneering Corp (IMRX): Submission of Matters to a Vote of Security Holders
Immuneering Corp (IMRX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. imrx-20260611 0001790340 FALSE 0001790340 2026-06-11 2026-06-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K __________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report
How this was made
The 30-second read
Why it matters
Director elections and auditor ratification are typically non-catalyst events; the main trading relevance is confirming governance mechanics completed as scheduled.
Market read
Confirms annual meeting outcomes (board seats and auditor ratification) with no new financial or operational catalyst.
What to watch
Traders should verify whether the proxy included any contested items or governance changes; this 8-K excerpt only shows vote counts, not strategic implications.
Background
The SEC 8-K Item 5.07 reports matters submitted to a vote of security holders at the company’s annual meeting.
Ticker impact
Immuneering reported 8-K voting results from its June 11, 2026 annual meeting, electing two directors and approving auditor ratification.
Limited near-term impact; any move would likely be sentiment/positioning rather than fundamentals.
The filing only documents shareholder vote tallies (director election and auditor ratification) without new business, clinical, or financial disclosures.
Market effects
None—no sector/regulatory/clinical read-across provided.
None indicated.
None indicated.
Counterpoint
If the market was uncertain about board composition or auditor continuity, the vote could reduce overhang, but the filing provides no qualitative change beyond election/ratification.
Key entities
- issuerImmuneering Corporation
Company filing the 8-K and reporting annual meeting voting results.
- auditorRSM US LLP
Independent registered public accounting firm whose appointment was ratified for the year ending Dec. 31, 2026.
- director_nomineePeter Feinberg
Elected Class II director based on the reported vote totals.
- director_nomineeLaurie B. Keating
Elected Class II director based on the reported vote totals.
